Craig A.Tooman
2013
In 2013, Craig A.Tooman earned a total compensation of $2.2M as Chief Financial Officer at Aratana Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $17,500 |
|---|---|
| Option Awards | $1,159,535 |
| Salary | $88,504 |
| Stock Awards | $941,787 |
| Other | $1,167 |
| Total | $2,208,493 |
ATooman received $1.2M in option awards, accounting for 53% of the total pay in 2013.
ATooman also received $17.5K in non-equity incentive plan, $88.5K in salary, $941.8K in stock awards and $1.2K in other compensation.
Rankings
In 2013, Craig A.Tooman's compensation ranked 3,554th out of 12,286 executives tracked by ExecPay. In other words, ATooman earned more than 71.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,554 out of 12,286 | 71st |
Division Manufacturing | 1,203 out of 4,612 | 74th |
Major group Chemicals And Allied Products | 328 out of 1,466 | 78th |
Industry group Drugs | 229 out of 1,160 | 80th |
Industry Pharmaceutical Preparations | 187 out of 890 | 79th |
Source: SEC filing on April 28, 2015.
ATooman's colleagues
We found four more compensation records of executives who worked with Craig A.Tooman at Aratana Therapeutics in 2013.